673858 |
JOURNAL OF CLINICAL MEDICINE |
Comparison of Three Different Internal Brace Augmentation Techniques for Scapholunate Dissociation: A Cadaveric Biomechanical Study |
2021-04-02 |
10.3390/jcm10071482 |
Park Il-Jung, Lim Dohyung, Maniglio Mauro, Shin Steven S., Chae Seungbum, Truong Victor, McGarry Michelle H., Lee Thay Q. |
673857 |
PHARMACEUTICS |
Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method |
2021-04-02 |
10.3390/pharmaceutics13040489 |
Klitgaard Mette, Müllertz Anette, Berthelsen Ragna |
673856 |
PHARMACEUTICS |
Ginsenoside Absorption Rate and Extent Enhancement of Black Ginseng (CJ EnerG) over Red Ginseng in Healthy Adults |
2021-04-02 |
10.3390/pharmaceutics13040487 |
Yoo Saebyul, Park Bom-I, Kim Do-hyun, Lee Sooyoung, Lee Seung-hoon, Shim Wang-Seob, Seo Yong Ki, Kang Kimoon, Lee Kyung-Tae, Yim Sung-Vin, Soung Do Yu, Kim Bo-Hyung |
673855 |
PHARMACEUTICS |
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors |
2021-04-02 |
10.3390/pharmaceutics13040483 |
Capone Emily, Lattanzio Rossano, Gasparri Fabio, Orsini Paolo, Rossi Cosmo, Iacobelli Valentina, De Laurenzi Vincenzo, Natali Pier Giorgio, Valsasina Barbara, Iacobelli Stefano, Sala Gianluca |
673854 |
PHARMACEUTICS |
Peptide-Based Strategies for Targeted Tumor Treatment and Imaging |
2021-04-02 |
10.3390/pharmaceutics13040481 |
Ayo Abiodun, Laakkonen Pirjo |
673853 |
PHARMACEUTICS |
Testing a Benchtop Wet-Milling Method for Preparing Nanoparticles and Suspensions as Hospital Formulations |
2021-04-02 |
10.3390/pharmaceutics13040482 |
Kawano Yayoi, Shimizu Yuichiro, Hanawa Takehisa |
673852 |
PHARMACEUTICS |
Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook |
2021-04-02 |
10.3390/pharmaceutics13040484 |
Karthikeyan Adhimoolam, Young Kim Na, Moniruzzaman Mohammad, Beyene Anteneh Marelign, Do Kyoungtag, Kalaiselvi Senthil, Min Taesun |
673851 |
PHARMACEUTICS |
A Model-Informed Drug Development (MIDD) Approach for a Low Dose of Empagliflozin in Patients with Type 1 Diabetes |
2021-04-02 |
10.3390/pharmaceutics13040485 |
Johnston Curtis K., Eudy-Byrne Rena J., Elmokadem Ahmed, Nock Valerie, Marquard Jan, Soleymanlou Nima, Riggs Matthew M., Liesenfeld Karl-Heinz |
673850 |
PHARMACEUTICS |
Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury |
2021-04-02 |
10.3390/pharmaceutics13040486 |
Zhang Guoli, Xie Fei, Sun Yunbo, Yu Xiang, Xiao Zhimei, Fang Rongzhen, Li Jingfei, Li Qian, Du Lina, Jin Yiguang |
673849 |
PHARMACEUTICS |
A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework |
2021-04-02 |
10.3390/pharmaceutics13040488 |
Pérez-Moraga Raul, Forés-Martos Jaume, Suay-García Beatriz, Duval Jean-Louis, Falcó Antonio, Climent Joan |